D

DOD Biotech PCL
SET:DOD

Watchlist Manager
DOD Biotech PCL
SET:DOD
Watchlist
Price: 1.62 THB -0.61%
Market Cap: 729.7m THB

Intrinsic Value

The intrinsic value of one DOD stock under the Base Case scenario is 2.94 THB. Compared to the current market price of 1.62 THB, DOD Biotech PCL is Undervalued by 45%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

DOD Intrinsic Value
2.94 THB
Undervaluation 45%
Intrinsic Value
Price
D
Worst Case
Base Case
Best Case

Valuation History
DOD Biotech PCL

What is Valuation History?
Ask AI Assistant
What other research platforms think about DOD?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is DOD valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for DOD Biotech PCL.

Explain Valuation
Compare DOD to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about DOD?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
DOD Biotech PCL

Current Assets 460.1m
Cash & Short-Term Investments 253.7m
Receivables 73.3m
Other Current Assets 133.1m
Non-Current Assets 650.3m
Long-Term Investments 2.6m
PP&E 510m
Intangibles 38.7m
Other Non-Current Assets 98.9m
Current Liabilities 105m
Accounts Payable 72.3m
Other Current Liabilities 32.6m
Non-Current Liabilities 60m
Long-Term Debt 37.8m
Other Non-Current Liabilities 22.2m
Efficiency

Free Cash Flow Analysis
DOD Biotech PCL

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
DOD Biotech PCL

Revenue
617.4m THB
Cost of Revenue
-405.3m THB
Gross Profit
212.1m THB
Operating Expenses
-170.1m THB
Operating Income
42m THB
Other Expenses
9m THB
Net Income
51m THB
Fundamental Scores

DOD Profitability Score
Profitability Due Diligence

DOD Biotech PCL's profitability score is 37/100. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin
ROE is Increasing
Sustainable 3Y Average Gross Margin
Net Margin is Increasing
37/100
Profitability
Score

DOD Biotech PCL's profitability score is 37/100. The higher the profitability score, the more profitable the company is.

DOD Solvency Score
Solvency Due Diligence

DOD Biotech PCL's solvency score is 71/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Negative Net Debt
Low D/E
71/100
Solvency
Score

DOD Biotech PCL's solvency score is 71/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

DOD Price Targets Summary
DOD Biotech PCL

There are no price targets for DOD.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for DOD is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one DOD stock?

The intrinsic value of one DOD stock under the Base Case scenario is 2.94 THB.

Is DOD stock undervalued or overvalued?

Compared to the current market price of 1.62 THB, DOD Biotech PCL is Undervalued by 45%.

Back to Top